HFE mutations, iron deficiency and overload in 10 500 blood donors

British Journal of Haematology

Volumn 114, Issue 2, 2001, Pages 474-484

  Jackson, H A ^a   Carter, K ^b   Darke, C ^c   Guttridge, M G ^a   Ravine, D ^b   Hutton, R D ^c   Napier, J A ^a   Worwood, M ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b Welsh Blood Service   (United Kingdom)

^c UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

Author keywords

Blood donation; HFE mutations; Iron deficiency; Iron overload; Population screening

Indexed keywords

FERRITIN; IRON; TRANSFERRIN;

ADULT; ANEMIA; ARTICLE; BLOOD DONOR; FEMALE; FERRITIN BLOOD LEVEL; GENE FREQUENCY; GENE MUTATION; GENETIC RISK; GENOTYPE; HEMOCHROMATOSIS; HETEROZYGOSITY; HIGH RISK POPULATION; HOMOZYGOSITY; HUMAN; IRON BINDING CAPACITY; IRON DEFICIENCY; IRON OVERLOAD; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; PRIORITY JOURNAL; SCREENING TEST; TRANSFERRIN BLOOD LEVEL; UNITED KINGDOM;

ADULT; ANEMIA, IRON-DEFICIENCY; BLOOD DONORS; COHORT STUDIES; FEMALE; GENOTYPE; HEMOCHROMATOSIS; HETEROZYGOTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; IRON; IRON OVERLOAD; MALE; MEMBRANE PROTEINS; MUTATION; REGRESSION ANALYSIS; WALES;

EID: 0034883430     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2001.02949.x     Document Type: Article

References (61)

1. Prevalence of abnormal iron studies in heterozygotes for hereditary hemochromatosis: An analysis of 255 heterozygotes
2. Population screening for haemochromatosis, a comparison of unbound iron binding capacity, transferrin saturation and C282Y genotyping in 5211 voluntary blood donors
3. Screening for hereditary haemochromatosis should be implemented now
4. Severity of iron overload in hemochromatosis: Effect of volunteer blood donation before diagnosis
5. Diagnosis of hemochromatosis in young subjects: Predictive accuracy of biochemical screening tests
6. The effect of HFE genotypes on measurements of iron overload in patients attending a health appraisal clinic
7. Screening for genetic haemochromatosis in blood samples with raised alanine aminotransferase
8. Hereditary hemochromatosis: Etiologic, pathologic, and clinical aspects
9. Population screening for hemochromatosis: Expectations based on a study of relatives of symptomatic patients
10. Hereditary haemochromatosis mutations (HFE) in patients with type II diabetes mellitus
11. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis
12. The significance of haemochromatosis gene mutations in the general population, implications for screening
13. Heterozygosity for the C282Y mutation in the hemochromatosis gene is associated with increased serum iron, transferrin saturation, and hemoglobin in young women: A protective role against iron deficiency?
14. Non-transferrin-bound iron is present in serum of hereditary haemochromatosis heterozygotes
15. The C282Y mutation of HFE is another male specific risk factor childhood acute lymphoblastic leukemia
16. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors
17. The iron phenotype of hemochromatosis heterozygotes
18. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis
19. The hemochromatosis founder mutation in HLA-H disrupts beta (2)-microglobulin interaction and cell surface expression
20. The hemochromatosis gene product complexes with the transferrin receptor and lowers its affinity for ligand binding
21. Idiopathic hemochromatosis, an iron storage disease
22. Haemochromatosis gene mutations C282Y and H63D are not increased in type 2 diabetic patients compared with the Canterbury (New Zealand) general population
23. C282Y mutation in HFE (haemochromatosis) gene and type 2 diabetes
24. Iron stores and iron absorption: Effects of repeated blood donations
25. Rapid detection of genetic mutations associated with haemochromatosis
26. Hereditary haemochromatosis: To screen or not - Conditions for screening are not yet fulfilled
27. Polymorphism in intron 4 of HFE may cause overestimation of C282Y homozygote prevalence in haemochromatosis
28. Crystal structure of the hemochromatosis protein HFE and characterization of its interaction with transferrin receptor
29. Food iron absorption in idiopathic hemochromatosis
30. Factor V Leiden and the common haemochromatosis mutation HFE C282Y: Is there an association in familial venous thromboembolic disease?
31. A survey of 2,851 patients with hemochromatosis: Symptoms and response to treatment
32. Geography of HFE C282Y and H63D mutations
33. The effect of HFE mutations on serum ferritin and transferrin saturation in the Jersey population
34. Polymorphism in intron 4 of HFE does not compromise haemochromatosis mutation results
35. Iron stores in male blood donors evaluated by serum ferritin
36. Genetics of hemochromatosis
37. Long-term survival in patients with hereditary hemochromatosis
38. A population-based study of the clinical expression of the hemochromatosis gene
39. Determination of serum iron and latent iron-binding capacity (LIBC)
40. Hereditary hemochromatosis in adults without pathogenic mutations in the hemochromatosis gene
41. A screening test for assessing iron status
42. Expression of hemochromatosis in homozygous subjects. Implications for early diagnosis and prevention
43. Heterozygosity for a hereditary hemochromatosis gene is associated with cardiovascular death in women
44. New mutations inactivating transferrin receptor 2 in hemochromatosis type 3
45. Compound heterozygous hemochromatosis genotype predicts increased iron and erythrocyte indices in women
46. High prevalence of the His63Asp HFE mutation in Italian patients with porphyria cutanea tarda
47. A simple genetic test identifies 90% of UK patients with haemochromatosis
48. Increased risk of acute myocardial infarction in carriers of the hemochromatosis gene Cys282Tyr mutation - A prospective cohort study in men in eastern Finland
49. Serum ferritin concentration and iron stores in normal subjects
50. Incidence of liver disease in people with HFE mutations
51. Ferritin
52. Genetics of haemochromatosis
53. Laboratory determination of iron status
54. Iron deficiency anaemia
55. Inborn errors of metabolism: Iron
56. Iron deficiency anaemia and iron overload
57. A single tube heteroduplex PCR for the common HFE genotypes
58. Hemochromatosis-associated mortality in the United States from 1979 to 1992: An analysts of multiple-cause mortality data
59. HFE gene knockout produces mouse model of hereditary hemochromatosis